Subscriptions

Please select a publication below.

Clinical Trials Advisor

Clinical Trials AdvisorClinical Trials Advisor

Clinical Trials Advisor is designed especially for the clinical trials professional charged with gathering submission-quality data while protecting the safety and welfare of study subjects. With 12 issues a year, you can be confident that you'll stay abreast of the latest developments in global clinical trial trends, changes in trial endpoints and regulations that govern drug and medical device clinical trials. Each issue highlights essential industry news and tested techniques you can use to keep your clinical trials safe, compliant and efficient. Your subscription also includes access to The Clinical Trials Advisor Regulatory Resource Center — a one-stop location for all the guidance, regulations and laws you’ll need to comply with U.S and international clinical trial requirements.

Read More

Drug GMP Report

Drug GMP ReportDrug GMP Report

For over 20 years, drug manufacturers have relied on Drug GMP Report for the latest on FDA’s interpretation and enforcement of cGMPs and Quality Systems Regulation — information you need to stay in compliance. Each monthly issue brings you the latest on FDA enforcement trends and warning letters, track and trace developments, international regulations and more. You’ll also get the latest on inspection hot spots, data integrity issues, EU pharmacovigilance initiatives, harmonization efforts and evolving trends in drug GMP enforcement. Plus, every issue, you get links to critical documents such as draft and final guidances, Form 483s, warning letters, proposed rules, full text of proposed legislation and many more.

Read More

Drug Industry Daily

DIDDrug Industry Daily

This daily electronic briefing delivers coverage of developments at the FDA, FTC, HHS and other key agencies and decision-making bodies that affect the pharmaceutical industry around the world. Each issue gives you the most up-to-date news on top issues, such as patent exclusivity, market globalization enforcement, EU pharmacovigilance, new inspection trends, advertising practices, FDA warning letters, recalls, approvals and more. It’s the fastest, most reliable way to make sure you’re an industry expert.

Read More

Generic Line

Generic LineGeneric Line

For over 25 years, Generic Line has been the leading resource of accurate, up-to-date news and analysis on FDA policies affecting generic drugs and drug patents. Each monthly issue keeps you and your firm up to date on crucial regulatory, legislative and business changes, including the latest twists in the establishment of a biosimilars approval pathway, what strategies are most successful in challenging blockbuster brands, and the FTC’s growing efforts to stop pay-for-delay agreements. Plus in every issue you get links to key documents, such as FDA guidances, warning letters, rules, full texts of proposed legislation and much more.

Read More

International Devices & Diagnostics Monitor

International Devices & Diagnostics MonitorInternational Devices & Diagnostics Monitor

International Devices & Diagnostics Monitor (IDDM) is a one-stop resource that brings you a complete, global picture of the medical device regulations that affect your business. Nowhere else will you find a more comprehensive collection of all the regulatory changes in the US, EU, Asia, Latin America, the Middle East, Australia and the rest of the world. Your subscription includes a weekly newsletter to keep you up to date with global regulations as changes happen, including complete text of all government documents.

Read More

International Pharmaceutical Regulatory Monitor

IPRMInternational Pharmaceutical Regulatory Monitor

For over 40 years, International Pharmaceutical Regulatory Monitor has helped drugmakers' stay on top of new and changing pharma regulations around the world. This monthly newsletter tracks relevant topics — counterfeiting, marketing authorization, joint inspections, changes in international patent protections, transparency in clinical trials, unannounced inspections — in the markets where you need to stay compliant. IPRM covers long-established regulatory leaders, the FDA, European Medicines Agency, Health Canada, Australia's TGA, the International Conference on Harmonisation and other key organizations around the globe. IPRM also covers Latin America, Asia, Africa and other growing markets. In each issue, you get English-language texts of important, hard-to-obtain proposals, regulations, guidelines and other documents to help ensure speedy reviews of your regulatory submissions and success at home and abroad.

Read More

The GMP Letter

The GMP LetterThe GMP Letter

For 30 years, devicemakers have relied on The GMP Letter for the latest on the FDA's interpretation and enforcement of cGMPs and the Quality Systems Regulation — information you need to stay in compliance. Each monthly issue brings you updates on the FDA’s approach to facility inspections, changes to the EU’s unannounced inspections and the latest on joint inspections in these and other jurisdictions. You’ll also get the latest on cybersecurity, recalls, CAPAs, MDR reporting and more. And you’ll get links to Form 483s, warning letters, closeout letters, FDA policy notices and other reports to ensure your quality assurance efforts are a success.

Read More